TP53 gene mutations in plasma DNA of cancer patients

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Genes, Chromosomes and Cancer

• Publication date

  1999-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1098-2264(199902)24:2<160::AID-GCC10>3.0.CO;2-CPMID 9885984
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• "Presence of Fetal DNA in Maternal Plasma and Serum" (1997), by Dennis Lo, et al

  2018cited by this paper
• Molecular detection of genetic alterations in the serum of colorectal cancer patients.

  1998cited by this paper
• Presence of fetal DNA in maternal plasma and serum.

  1997cited by this paper
• K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer.

  1997cited by this paper
• Microsatellite alterations in plasma DNA of small cell lung cancer patients

  1996cited by this paper
• Microsatellite alterations in serum DNA of head and neck cancer patients

  1996cited by this paper
• Clinical implications of the p53 tumor-suppressor gene.

  1993cited by this paper
• PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA.

  1991cited by this paper
• Neoplastic characteristics of the DNA found in the plasma of cancer patients.

  1989cited by this paper
• Spontaneous release of DNA by human blood lymphocytes as shown in an in vitro system.

  1975cited by this paper

• Circulating Tumor DNA Is a Variant of Liquid Biopsy with Predictive and Prognostic Clinical Value in Breast Cancer Patients

  2023cites this paper
• Investigation of promoter methylation patterns association with genes expression profile of ISL1, MGMT and DMNT3b in tissue of breast cancer patients

  2022cites this paper
• The contribution of the 20th century discoveries on the circulating DNA as biomarkers for cancer screening.

  2020cites this paper
• Potential clinical applications of circulating cell-free DNA in ovarian cancer patients

  2018cites this paper
• Role of Circulating Tumor Cells and Cell-Free Tumor Deoxyribonucleic Acid Fragments as Liquid Biopsy Materials in Breast Oncology

  2017cites this paper
• Emerging Biomarkers of the Future: Changing Clinical Practice for 2020

  2016cites this paper
• Circulating DNA as biomarker in breast cancer

  2015cites this paper
• From the Genetic Make‐Up to the Molecular Signature of Non‐Coding RNA in Breast Cancer

  2014cites this paper
• Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance

  2014cites this paper
• Biomarkers for the clinical management of breast cancer: International perspective

  2013cites this paper
• Hide and seek: tell-tale signs of breast cancer lurking in the blood

  2012cites this paper
• Methylation patterns in cell‐free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients

  2011cites this paper
• Oncoproteins and Early Tumor Detection

  2011cites this paper
• Isolation of Nucleic Acids from Body Fluids

  2009cites this paper
• Levels of VEGF-A mRNA in plasma from patients with colorectal carcinoma as possible surrogate marker of angiogenesis

  2008cites this paper
• Quantification of Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer

  2008cites this paper
• Detection of Serum Free DNA Hypermethylation in Surgically Resected Adenocarcinoma of the Lung

  2008cites this paper
• Prognostic Value of LISCH7 mRNA in Plasma and Tumor of Colon Cancer Patients

  2007cites this paper
• Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients

  2007cites this paper
• Genomic profiling of circulating plasma RNA for the analysis of cancer.

  2007cites this paper
• Molecular Diagnostics and Genetics

  2007cites this paper
• Postcollection synthesis of ethyl glucuronide by bacteria in urine may cause false identification of alcohol consumption.

  2007cites this paper
• Postcollection Synthesis of Ethyl Glucuronide by Bacte- ria in Urine May Cause False Identification of Alcohol

  2007cites this paper
• Circulating nucleic acids (CNAs) and cancer--a survey.

  2007cites this paper
• PrognosticValue of LISCH 7 mRNA in Plasma and Tumor of Colon Cancer Patients

  2007cites this paper
• Thymidylate Synthase Messenger RNA Expression in Plasma from Patients with Colon Cancer: Prognostic Potential

  2006cites this paper
• Whole genome amplification of plasma-circulating DNA enables expanded screening for allelic imbalance in plasma.

  2006cites this paper
• Circulating DNA and Lung Cancer

  2006cites this paper
• The effect of automated test rejection on repeat requesting

  2006cites this paper
• Plasma DNA restoration for PCR applications

  2006cites this paper
• Quantitative detection of p53 mutations in plasma DNA from tobacco smokers.

  2006cites this paper
• Circulating Nucleic Acids in Plasma or Serum (CNAPS) as Prognostic and Predictive Markers in Patients with Solid Neoplasias

  2005cites this paper
• Original Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: Follow-up study and prognostic significance

  2005cites this paper
• Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?

  2005cites this paper
• Lung cancer-related genes in the blood.

  2004cites this paper
• Detection of Circulating Tumour DNA in the Blood (Plasma/Serum) of Cancer Patients

  2004cites this paper
• TP53 Gene in Blood Plasma DNA of Tumor Patients

  2004cites this paper
• Microsatellite Alterations as Diagnostic and Prognostic Molecular Markers in Patients With Cancer

  2004cites this paper
• Cancer Diagnostics

  2004cites this paper
• Hypermethylation of p 16 INK 4 a in Chinese lung cancer patients : biological and clinical implications

  2003cites this paper
• Hypermethylation of p16INK4a in Chinese lung cancer patients: biological and clinical implications.

  2003cites this paper
• Tumor-speci¢c DNA in plasma of breast cancer patients

  2002cites this paper
• Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival.

  2002cites this paper
• Persistence of tumor DNA in plasma of breast cancer patients after mastectomy

  2002cites this paper
• Tumor-specific DNA in plasma of breast cancer patients

  2002cites this paper
• p14ARF promoter hypermethylation in plasma DNA as an indicator of disease recurrence in bladder cancer patients.

  2002cites this paper
• Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells

  2002cites this paper
• Molecular biology of lung cancer: clinical implications.

  2002cites this paper
• Molecular biology of lung cancer: clinical implications.

  2002cites this paper
• Clinical significance of plasma nucleosome levels in cancer patients.

  2001cites this paper
• Correspondence re: F. Coulet et al., Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis. Cancer Res., 60: 707-709, 2000.

  2001cites this paper
• p 53 Mutation in Plasma DNA and Its Prognostic Value in Breast Cancer Patients 1

  2001cites this paper
• Isolation of circulating DNA in the serum of cancer patients

  2001cites this paper
• p53 mutation in plasma DNA and its prognostic value in breast cancer patients.

  2001cites this paper
• Breast cancer: contribution of molecular biology to the management of the disease

  2001cites this paper
• Trends in biomarker research for cancer detection.

  2001cites this paper
• Heterogeneous tumor clones as an explanation of discordance between plasma DNA and tumor DNA alterations

  2001cites this paper
• Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: follow-up study and prognostic significance.

  2000cites this paper
• Telomerase RNA as a detection marker in the serum of breast cancer patients.

  2000cites this paper
• Tumor DNA in plasma of breast cancer patients. Relation to treatment

  2000cites this paper
• Detection of tumor mutant APC DNA in plasma of patients with sporadic colorectal cancer.

  2000cites this paper
• DNA Alterations in the Plasma and Serum of Cancer Patients: A Molecular Tumor Marker

  2000cites this paper
• Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer.

  1999cites this paper
• Molecular pathogenesis of lung cancer.

  1999cites this paper
• Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations.

  1999influential citation
• The University of Bradford Institutional Repository

  year unknowncites this paper